Citation Impact
Citing Papers
Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study
2012
Topographical and Temporal Diversity of the Human Skin Microbiome
2009 StandoutScience
Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine.
2015
Keratinocyte Overexpression of IL-17C Promotes Psoriasiform Skin Inflammation
2013
The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies
2012
The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients
2006
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people: systematic review and economic evaluation
2017
Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation
2019 StandoutNobel
Pathologists’ diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study
2017
Psoriasis
2014
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Dermal γδ T cells — A new player in the pathogenesis of psoriasis
2013
Atopic Dermatitis
2008 Standout
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study
2016
HLA-Cw6 homozygosity in plaque psoriasis is associated with streptococcal throat infections and pronounced improvement after tonsillectomy: A prospective case series
2016
Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis
2009
Psoriasis
2009 Standout
Psoriasis: epidemiology
2007
IL-12 protects from psoriasiform skin inflammation
2016
Adherence to medication in patients with psoriasis: a systematic literature review
2012
Prevalence and Phenotype of Concurrent Psoriasis and Inflammatory Bowel Disease
2017
The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis
2014
The microbiota in adaptive immune homeostasis and disease
2016 StandoutNature
Heterogeneity of Inflammatory and Cytokine Networks in Chronic Plaque Psoriasis
2012
Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis
2012
Pathogenesis and clinical features of psoriasis
2007 Standout
Psoriasis and Other Complex Trait Dermatoses: From Loci to Functional Pathways
2011
Nucleotide signalling during inflammation
2014 StandoutNature
Halting angiogenesis by non-viral somatic gene therapy alleviates psoriasis and murine psoriasiform skin lesions
2010
The IL-17 Family of Cytokines in Health and Disease
2019
Efficacy of systemic therapies for moderate‐to‐severe psoriasis: a systematic review and meta‐analysis of long‐term treatment
2012
The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings
2012
The genetics of psoriasis, psoriatic arthritis and atopic dermatitis
2004
Polymorphisms of the IL12B and IL23R Genes Are Associated with Psoriasis
2008
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study
2013
Pathogenesis and therapy of psoriasis
2007 StandoutNature
Atopic dermatitis
2015 Standout
Navigating transdermal diffusion with multiphoton fluorescence lifetime imaging
2008
Dermatologist-level classification of skin cancer with deep neural networks
2017 StandoutNature
Filaggrin's Fuller Figure: A Glimpse into the Genetic Architecture of Atopic Dermatitis
2007
Immunopathogenesis of psoriasis
2007
Guidelines of care for the management of psoriasis and psoriatic arthritis
2009
Psoriasis
2021 Standout
Psoriasis Triggered by Toll-like Receptor 7 Agonist Imiquimod in the Presence of Dermal Plasmacytoid Dendritic Cell Precursors
2004
IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis
2012
PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing
2008 Standout
Effect of tonsillectomy on psoriasis: A systematic review
2014
Psoriasis pathogenesis and the development of novel targeted immune therapies
2017
Photodynamic antimicrobial chemotherapy (PACT)
1998
Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years
2012
Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence
2012 Standout
Psoriasis
2015 Standout
Identification of Putative Target Genes of the Transcription Factor RUNX2
2013 StandoutNobel
Integrins as “functional hubs” in the regulation of pathological angiogenesis
2009
SKINOMICS: Transcriptional Profiling in Dermatology and Skin Biology
2012
Interleukin-17 and Type 17 Helper T Cells
2009 Standout
Erythrodermic psoriasis: pathophysiology and current treatment perspectives
2016
Broad-Spectrum Antibiotic or G-CSF as Potential Countermeasures for Impaired Control of Bacterial Infection Associated with an SPE Exposure during Spaceflight
2015 StandoutNobel
Meta-Analysis Derived (MAD) Transcriptome of Psoriasis Defines the “Core” Pathogenesis of Disease
2012
Analysis of the Paired TCR α- and β-chains of Single Human T Cells
2012
The development of allergic inflammation
2008 StandoutNature
Crohn's disease
2016 Standout
Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis
2012
Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
2011
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Epidermal barrier formation and recovery in skin disorders
2006
Psoralen Photobiology: Recent Advances
1996
Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies
2001
IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis
2017
The long-term efficacy and safety of new biological therapies for psoriasis
2006
The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants
2014
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
2012
Comparison of cutaneous tolerance and efficacy of calcitriol 3 μg g−1ointment and tacrolimus 0·3 mg g−1ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial
2007
Immunopathogenesis of Psoriasis
2007
Expanding the Psoriasis Disease Profile: Interrogation of the Skin and Serum of Patients with Moderate-to-Severe Psoriasis
2012
The Psoriatic Transcriptome Closely Resembles That Induced by Interleukin-1 in Cultured Keratinocytes
2007
Ubiquitination and phosphorylation in the regulation of NOD2 signaling and NOD2-mediated disease
2012
New insights of T cells in the pathogenesis of psoriasis
2012
A multicenter, randomized, open-label pilot trial assessing the efficacy and safety of etanercept 50 mg twice weekly followed by etanercept 25 mg twice weekly, the combination of etanercept 25 mg twice weekly and acitretin, and acitretin alone in patients with moderate to severe psoriasis
2016
Molecular Dissection of Psoriasis: Integrating Genetics and Biology
2009
Disease Severity, Quality of Life and Health Care in Plaque-Type Psoriasis: A Multicenter Cross-Sectional Study in Germany
2008
Ulcerative colitis
2020 Standout
Psoriasis – as an autoimmune disease caused by molecular mimicry
2009
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2)
2015
Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes
2009
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Liposomes in topical photodynamic therapy
2012
Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents
2018
Psoriasis: what we have learned from mouse models
2010
Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA
2015 StandoutNobel
Anti-cytokine therapies for psoriasis
2011
A Genome-Wide Association Study of Psoriasis and Psoriatic Arthritis Identifies New Disease Loci
2008
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
2014 Standout
The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses
2013
Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer
2008
The hairless mouse in skin research
2008
The Th17 Pathway and Inflammatory Diseases of the Intestines, Lungs, and Skin
2011
Physical Mechanisms of Generation and Deactivation of Singlet Oxygen
2003 Standout
Fumaric acid and its derivatives in the treatment of psoriasis vulgaris: our experience in forty-one patients.
2009
Increased expression of interleukin‐17 pathway genes in nonlesional skin of moderate‐to‐severe psoriasis vulgaris
2015
Management of psoriasis in adolescence
2014
Generalized pustular psoriasis: a review and update on treatment
2018
Melanoma Computer-Aided Diagnosis
2004
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris
2014
Regulatory T Cells and Human Disease
2020 StandoutNobel
Metal Complexes as Photo- and Radiosensitizers
1999
Comparison of Biologics and Oral Treatments for Plaque Psoriasis
2020
Triggering psoriasis: the role of infections and medications
2007
Supramolecular Antibacterial Materials for Combatting Antibiotic Resistance
2018
Efficacy and safety of fumaric acid esters in the long‐term treatment of psoriasis – A retrospective study (FUTURE)
2009
Psoriasis Pathogenesis and Treatment
2019 Standout
The Psoriasis Symptom Diary: development and content validity of a novel patient‐reported outcome instrument
2013
IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential
2012
The Runx2 Osteogenic Transcription Factor Regulates Matrix Metalloproteinase 9 in Bone Metastatic Cancer Cells and Controls Cell Invasion
2005
‘Happy’ drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network
2014
Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm®- and placebo-controlled trial (BRIDGE)
2016
Immunology of Psoriasis
2014 Standout
Fluorescence Lifetime Measurements and Biological Imaging
2010 Standout
Nail Psoriasis: A Review of Treatment Options
2016
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Charge Transfer Interactions in the Generation of Singlet Oxygen O2(1Δg) by Strong Electron Donors
1999
Machine Learning in Medicine
2019 Standout
Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis
2018
A systematic review of worldwide epidemiology of psoriasis
2016
Ezrin, Maspin, Peroxiredoxin 2, and Heat Shock Protein 27: Potential Targets of a Streptococcal-Induced Autoimmune Response in Psoriasis
2010
Porphyrin-based photosensitizers for use in photodynamic therapy
1998
Two-Photon Photosensitized Production of Singlet Oxygen in Water
2004
Control of skin cancer by the circadian rhythm
2011 StandoutNobel
JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines
2015
Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells
2007
Improvement of Psoriasis after Tonsillectomy Is Associated with a Decrease in the Frequency of Circulating T Cells That Recognize Streptococcal Determinants and Homologous Skin Determinants
2012
BODIPY dyes in photodynamic therapy
2012 Standout
Effect of Sensitizer Protonation on Singlet Oxygen Production in Aqueous and Nonaqueous Media
2007
Chemistry of Biologically Important Synthetic Organoselenium Compounds
2001 Standout
Proenkephalin+regulatory T cells expanded by ultraviolet B exposure maintain skin homeostasis with a healing function
2020 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
DNA Cross-Linking Agents as Antitumor Drugs
1998
The interpretation of long-term trials of biologic treatments for psoriasis: trial designs and the choices of statistical analyses affect ability to compare outcomes across trials
2013
Reversible Photochemical Control of Singlet Oxygen Generation Using Diarylethene Photochromic Switches
2014 StandoutNobel
A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis
2018
Therapeutic antibodies that target inflammatory cytokines in autoimmune diseases
2015
Psoralen photoactivation promotes morphological and functional changes in fibroblasts in vitro reminiscent of cellular senescence
1998
HLA-Cw6-positive patients with psoriasis show improved response to methotrexate treatment
2017
Computer Aided Diagnostic Support System for Skin Cancer: A Review of Techniques and Algorithms
2013
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
THE GENETICS OF PSORIASIS AND AUTOIMMUNITY
2005
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Topical treatments for chronic plaque psoriasis of the scalp: a systematic review
2013
Nod2 Deficiency Augments Th17 Responses and Exacerbates Autoimmune Arthritis
2018 StandoutNobel
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
2020 Standout
Apremilast for the treatment of moderate‐to‐severe palmoplantar psoriasis: results from a double‐blind, placebo‐controlled, randomized study
2017
Consensus Guidelines for the Management of Plaque Psoriasis
2012
Signaling through Purinergic Receptors for ATP Induces Human Cutaneous Innate and Adaptive Th17 Responses: Implications in the Pathogenesis of Psoriasis
2013
Time-Resolved Absorption Spectrum of Singlet Oxygen in Solution
1998
Works of Sergio Chimenti being referenced
Efficacy and safety of long-term infliximab therapy in moderate to severe psoriasis and psoriatic arthritis
2006
Identical TCR β-Chain Rearrangements in Streptococcal Angina and Skin Lesions of Patients with Psoriasis Vulgaris
2006
Short Contact Therapy with Tazarotene in Psoriasis Vulgaris
2006
Topical use of calcitriol 3 µg/g ointment in the treatment of mild‐to‐moderate psoriasis: results from an open‐label study
2005
The specific effects of 8-methoxypsoralen photoadducts on cell growth: HPLC analysis of monoadduct and crosslink formation in cells exposed to split-dose treatment
1994
Psoriatic Arthritis and CARD15 Gene Polymorphisms: No Evidence for Association in the Italian Population
2004
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study
2015
Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial
2015
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk
2015
Regional distribution of psoriasis in Italy
2007
The Impact of Methodological Approaches for Presenting Long-Term Clinical Data on Estimates of Efficacy in Psoriasis Illustrated by Three-Year Treatment Data on Infliximab
2010
Scalp psoriasis: European consensus on grading and treatment algorithm
2009
Complete Resolution of Erythrodermic Psoriasis in an HIV and HCV Patient Unresponsive to Antipsoriatic Treatments after Highly Active Antiretroviral Therapy (Ritonavir, Atazanavir, Emtricitabine, Tenofovir)
2012
Childhood Nail Psoriasis: A Useful Treatment with Tazarotene 0.05%
2007
Efficacy of Efalizumab in Psoriasis Patients Previously Treated with Tumour Necrosis Factor Blockers
2009
Local treatment of chronic cutaneous leg ulcers with recombinant human granulocyte‐macrophage colony‐stimulating factor
2002
Treatment of erythrodermic psoriasis with etanercept
2006
Infliximab in Psoriasis and Psoriatic Arthritis
2013
Fine Mapping of the PSORS4 Psoriasis Susceptibility Region on Chromosome 1q21
2001
Adalimumab for severe psoriasis and psoriatic arthritis: An open-label study in 30 patients previously treated with other biologics
2007
Psoralen-protein photochemistry — a forgotten field
1995
Fate of UVB-induced p53 mutations in SKH-hr1 mouse skin after discontinuation of irradiation: relationship to skin cancer development
2005
Continuous Treatment of Plaque-Type Psoriasis with Etanercept: An Observational Long-Term Experience
2010
Three-Point Checklist of Dermoscopy
2004
Dermoscopic diagnosis by a trained clinician vs. a clinician with minimal dermoscopy training vs. computer-aided diagnosis of 341 pigmented skin lesions: a comparative study
2002
Coexpression of Bone Sialoprotein (BSP) and the Pivotal Transcriptional Regulator of Osteogenesis, Cbfa1/Runx2, in Malignant Melanoma
2003
A 308‐nm monochromatic excimer light in the treatment of palmoplantar psoriasis
2006
CLinical experience acquired with the efalizumab (Raptiva®) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial
2006
Ustekinumab Treatment of Erythrodermic Psoriasis Occurring after Physical Stress: A Report of Two Cases
2013
Allele-Specific Cytokine Responses at the HLA-C Locus: Implications for Psoriasis
2011
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis
2009
Actinic keratosis treated with an immune response modifier: a case report of six patients
2003
Co-Localization of Susceptibility Loci for Psoriasis (PSORS4) and Atopic Dermatitis (ATOD2) on Human Chromosome 1q21
2006
Recent Patents and New Strategies in the Treatment of Psoriasis
2006
A classification of psoriasis vulgaris according to phenotype
2006
Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)
2015
TNF-α antagonists and nail psoriasis: an open, 24-week, prospective cohort study in adult patients with psoriasis
2012
Increased surface expression of class I MHC molecules on immunogenic cells derived from the xenogenization of P815 mastocytoma cells with 8‐methoxypsoralen and long‐wavelength ultraviolet radiation
1995
European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey
2006
Treatment with 8-MOP and UVA enhances MHC class I synthesis in RMA cells: preliminary results
1995
Adalimumab in the Treatment of Immune-Mediated Diseases
2014
Dermoscopic and histopathologic diagnosis of equivocal melanocytic skin lesions
2002
IL-6 as a Druggable Target in Psoriasis: Focus on Pustular Variants
2014
Clobetasol propionate foam 0.05% as a novel topical formulation for plaque‐type and scalp psoriasis
2007
Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis
2010
Etanercept provides an effective, safe and flexible short- and long-term treatment regimen for moderate-to-severe psoriasis: a systematic review of current evidence
2012
Effect of anti-tumor necrosis factor-α therapies on body mass index in patients with psoriasis
2008
Pharmacogenetics of psoriasis:HLA-Cw6but notLCE3B/3Cdeletion norTNFAIP3polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab
2013
Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment
2011
A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study
2010
Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population.
2003
Influence and Variation of the Body Mass Index in Patients Treated with Etanercept for Plaque-Type Psoriasis
2009
Efficacy and tolerability of 5-aminolevulinic acid 0.5% liposomal spray and intense pulsed light in wrinkle reduction of photodamaged skin
2011
Dermoscopy of pigmented skin lesions.
2001
Fumaric acid esters in the treatment of psoriasis: an Italian experience
2004
Imiquimod Treatment of Superficial and Nodular Basal Cell Carcinoma
2005